** Shares in French market research firm Ipsos ISOS.PA
drop 6.6% after what Midcap Partners analyst called a "mixed" Q1
performance
** Sales growth in EMEA and Asia was offset by a downturn in
the Americas, weighed down by the U.S.
** For the U.S., Ipsos cites a moderate recovery by major
tech customers, termination of some major Public Affairs
contracts, a wait-and-see attitude ahead of the presidential
elections, and a temporary setback in the healthcare sector
** Midcap Partners notes Ipsos is dependent on the state of
the world economy and consumer trends, with its consumer segment
accounting for almost a half of its business
** "The (2024) dynamic will depend on the recovery of TMT
customers (17% of 2023 sales) and US tech (7% of 2023 sales),
the recovery of China (7% of 2023 sales)," the broker says
** Ipsos confirms its 2024 outlook for organic sales growth
of more than 4% and an operating margin of around 13%
** The shares are on track for their worst day since July 26
if losses hold
(Reporting by Dimitri Rhodes)
((Dimitri.Rhodes@thomsonreuters.com))